VCEL earnings date and last-quarter result: next report 2026-07-30, last quarter in line, P/E 103.87. Updated 2026-07-23.
Vericel (VCEL) Research Hub
Vericel (VCEL) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 43.04 USD (+1.20%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 103.87, market cap 2.29B. This hub links to the full technical, earnings and options research available for VCEL.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 43.04 USD (+1.20%) |
| 52-week range | 37.21 USD – 49.32 USD |
| Trend regime | Range |
| 14-day RSI | 69.2 (Bullish) |
| Trailing P/E | 103.87 |
| Market cap | 2.29B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for VCEL
Covered Call on VCEL: how it works, illustrative setup around the real 43.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VCEL: how it works, illustrative setup around the real 43.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VCEL: how it works, illustrative setup around the real 43.04 USD price, max profit/loss, breakeven and when to use it. Educational.
VCEL technical analysis: range, last 43.04 USD, RSI 69.2, 52w range 37.21 USD–49.32 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VCEL in?
Vericel (VCEL) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VCEL in an uptrend or downtrend?
As of 2026-10-26, VCEL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VCEL's trailing P/E ratio?
VCEL's trailing P/E is 103.87, with a market cap of 2.29B. See the earnings research page for full valuation detail.
When does VCEL next report earnings?
VCEL is next scheduled to report earnings on 2026-07-30.